A detailed history of Main Street Group, LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Main Street Group, LTD holds 3,986 shares of ABBV stock, worth $729,756. This represents 0.36% of its overall portfolio holdings.

Number of Shares
3,986
Previous 4,168 4.37%
Holding current value
$729,756
Previous $714,000 10.22%
% of portfolio
0.36%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $29,818 - $36,278
-182 Reduced 4.37%
3,986 $787,000
Q2 2024

Aug 05, 2024

SELL
$154.79 - $180.76 $9,596 - $11,207
-62 Reduced 1.47%
4,168 $714,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $70,800 - $80,670
443 Added 11.7%
4,230 $770,000
Q4 2023

Feb 15, 2024

BUY
$137.6 - $154.97 $521,091 - $586,871
3,787 New
3,787 $587 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Main Street Group, LTD Portfolio

Follow Main Street Group, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Group, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Group, LTD with notifications on news.